ask="100.00"
ask_size="600"
average_daily_volume="301132"
bid="N/A"
bid_size="N/A"
book_value="3.79"
change="+0.95"
change_from_200_day_moving_average="3.65"
change_from_50_day_moving_average="0.94"
change_from_52_week_high="-3.50"
change_From_52_week_low="14.18"
change_in_percent="+3.47%"
close="28.30"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.07"
ebitda="-37.24M"
eps_estimate_current_year="-2.36"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-3.03"
ex_dividend_date="N/A"
float_shares="14358000"
high="28.34"
high_52_weeks="31.80"
last_trade_date="2/14/2017"
last_trade_price="28.30"
last_trade_size="4118"
last_trade_time="4:00pm"
low="27.28"
low_52_weeks="14.12"
market_capitalization="606.53M"
moving_average_200_day="24.65"
moving_average_50_day="27.36"
name="Aclaris Therapeutics
Inc."
notes="N/A"
one_year_target_price="38.17"
open="27.52"
pe_ratio="N/A"
peg_ratio="-0.19"
percent_change_from_200_day_moving_average="+14.83%"
percent_change_from_50_day_moving_average="+3.45%"
percent_change_from_52_week_high="-11.01%"
percent_change_from_52_week_low="+100.42%"
previous_close="27.35"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.22"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21432000"
short_ratio="6.47"
stock_exchange="NMS"
symbol="ACRS"
volume="129949"
weeks_range_52="14.12 - 31.80"
